You must have the latest Flash plugin to view this slideshow. 63-year history of research and clinical excellence

Hormone-depleting drug shows promise against localized high-risk prostate tumors

May 16, 2012

Dana-Farber researchers have demonstrated that a hormone-depleting drug can help eliminate or nearly eliminate aggressive prostate cancers that have yet to spread beyond the prostate.

Paths of Progress app expands to Android and Kindle Fire
May 15, 2012

Paths of Progress, Dana-Farber’s award-winning cancer research magazine, is now available as a free app for iPad, Android and Kindle Fire tablets.

Dana-Farber Cancer Institute recognizes Oncology Nursing Month
May 14, 2012

During Oncology Nursing Month, Dana-Farber proudly recognizes its dedicated, expert nursing professionals, who serve many functions along the continuum of care. Our nurses also received recognition from national peers and local patients.

New under the sun: recurrent genetic mutations in melanoma
May 09, 2012

Scientists from Dana-Farber and the Broad Institute have sequenced 25 melanoma tumors and confirmed the long-held suspicion that chronic sun exposure plays a role in skin cancer.

Cancer's epicentre (The Economist)

April 07, 2012

Epigenetics was the subject of a particularly interesting session, held on April 1st, at a meeting of the American Association for Cancer Research in Chicago. James Bradner, MD, described how his group has shown that a substance known as JQ1, which inhibits an epigenetic regulator called BRD4, blocks the activity of a gene by the name of Myc.

Breast cancer hot topic: Clear tumor margins (abcnews.com)
March 26, 2012

Breast cancer surgeons have been having an ongoing discussion on how much tissue to breast tissue to remove when removing a tumor. Dr. Mehra Golshan said that with ductal carcinoma in situ (DCIS), a very treatable, early stage cancer, smaller margins are acceptable and appropriate.

Marker may predict who responds to chemo (United Press International)
March 22, 2012

Dr. Andrea Richardson and colleagues have identified a genetic marker that may predict which aggressive "triple negative" breast cancers and certain ovarian cancers will likely respond to platinum-based chemotherapies.

Aspirin and cancer study: Daily use reduces cancer (Fox News)
March 22, 2012

Dr. Charles Fuchs explains how aspirin can play a significant role in the fight against cancer.

Music Heals the Soul

May 23, 2012

6:00 PM - 10:00 PM

Royal Sonesta Hotel, Cambridge, Mass.

Join us at the Royal Sonesta Hotel in Cambridge for the 5th annual Music Heals the Soul event to support the Leonard P. Zakim Center for Integrative Therapies at Dana-Farber Cancer Institute. Come meet and experience the talent of our amazing therapists and honor Ursula Matulonis, MD for a night filled with music and dancing.

Event website

more

Stop & Shop Triple Winner Program

May 18, 2012

April 13 through July 12, Stop & Shop customers have the opportunity to help support pediatric brain tumor care and research at Dana-Farber Cancer Institute through Stop & Shop's annual Triple Winner Game®. Customers who give a $1 contribution to the Jimmy Fund receive a Triple Winner Game card and receive free store products, coupons, gift cards, or cash prizes up to $10,000.

Stop & Shop Triple Winner Program 

more

Women's Exercise Class(9)

May 18, 2012

1:30 PM - 2:30 PM

Bodyscapes Longwood Area

Please call 617-632-6779  to register or e-mail nancy_campbell@dfci.harvard.edu. Held Tuesday and Friday each week, adult female patients and survivors of all skill levels are welcome to attend this no-cost fitness class, led by a Dana-Farber exercise physiologist. It features a mix of strength training, stretching, and core muscle work. No experience necessary, but registration is required and medical clearance is needed from physician.

more

Brain Tumor Support Group(4)

May 18, 2012

1:30 PM - 3:00 PM

Smith Building Room 764

Brain Tumor Support Group more

  •  
  • Patient referral information, clinical resources and more.

  • Request an Appointment


    For adults:
    877-442-3324 (877-442-DFCI)

    For children:
    888-733-4662 (888-PEDI-ONC)

    Or complete the online form.

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance 

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog